ALLMedicine™ Hypertriglyceridemia Center

Mar 5th, 2021 - Hemophagocytic lymphohistiocytosis (HLH) is a rarely recognized hyperinflammatory condition of high death risk. The objective was to describe a case of HLH in a patient with multiple sclerosis (MS) treated with ocrelizumab. Clinical observation, l...

Mar 2nd, 2021 - This review examines recent contradictory large, well-controlled randomized control trials assessing the effects of omega-3 fatty acids and colchicine on cardiovascular (CV) outcomes. The Reduction of Cardiovascular Events with Icosapent Ethyl-Int...

Feb 23rd, 2021 - Hypertriglyceridemia induced acute pancreatitis (HIAP) is the third common cause of acute pancreatitis. HIAP can result in recurrent attacks of severe AP with significant morbidity and mortality. Hypertriglyceridemia (HTG) could be primary or seco...

Feb 22nd, 2021 - Dyslipidemia is an emerging metabolic disorder among pesticide-exposed agricultural workers, and this study was aimed to explore biomarkers of hypertriglyceridemia susceptibility. This cross-sectional study recruited 72 pesticide-exposed subjects ...

Feb 21st, 2021 - Pemafibrate, a selective PPARα modulator, has the beneficial effects on serum triglycerides (TGs) and very low density lipoprotein (VLDL), especially in patients with diabetes mellitus or metabolic syndrome. However, its effect on the low density ...

Mar 3rd, 2020 - Hypertriglyceridemia (HTG) is a very common problem in clinical practice with a prevalence of approximately 10%.1 Plasma triglyceride (TG) concentration is a biomarker for TG rich lipoproteins (TRL) and their remnants, which have emerged as import...

Jan 10th, 2019 - The 2018 AHA/ACC Guideline on the Management of Blood Cholesterol was a welcome update from the 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.1 Our new guideline reinforces the...

Dec 16th, 2018 - Because the hallmark of type 1 diabetes is absent or near-absent β-cell function, insulin treatment is essential for individuals with type 1 diabetes. Insufficient provision of insulin causes not only hyperglycemia but also systematic metabolic di...

Aug 13th, 2013 - Endocrine society releases guidelines on diagnosis and management of hypertriglyceridemia.|2013| ,|therapeutic use,diagnosis,drug therapy,etiology,therapy,therapeutic use,blood,

Sep 10th, 2012 - The aim was to develop clinical practice guidelines on hypertriglyceridemia. The Task Force included a chair selected by The Endocrine Society Clinical Guidelines Subcommittee (CGS), five additional experts in the field, and a methodologist. The a...

Mar 5th, 2021 - Hemophagocytic lymphohistiocytosis (HLH) is a rarely recognized hyperinflammatory condition of high death risk. The objective was to describe a case of HLH in a patient with multiple sclerosis (MS) treated with ocrelizumab. Clinical observation, l...

Mar 3rd, 2021 - Fenofibrate is a peroxisome proliferator-activated receptor (PPAR) alpha agonist indicated as an adjunct to diet: •To reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed ...

Mar 2nd, 2021 - This review examines recent contradictory large, well-controlled randomized control trials assessing the effects of omega-3 fatty acids and colchicine on cardiovascular (CV) outcomes. The Reduction of Cardiovascular Events with Icosapent Ethyl-Int...

Mar 2nd, 2021 - Rosuvastatin tablets are an HMG Co-A reductase inhibitor indicated for: • adult patients with hypertriglyceridemia as an adjunct to diet ( 1.3) •  adult patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to ...

Mar 1st, 2021 - Simvastatin tablets USP are an HMG-CoA reductase inhibitor (statin) indicated as an adjunctive therapy to diet to: Reduce the risk of total mortality by reducing CHD deaths and reduce the risk of non-fatal myocardial infarction, stroke, and the ne...

Oct 14th, 2020 - Calculating the ratio between serum triglyceride and apolipoprotein B levels may help rule out patients with hypertriglyceridemia who are at low risk of developing hypertriglyceridemic pancreatitis (HTGP), and so better guide management, suggests ...

Oct 14th, 2020 - Calculating the ratio between serum triglyceride and apolipoprotein B levels may help rule out patients with hypertriglyceridemia who are at low risk of developing hypertriglyceridemic pancreatitis (HTGP), and so better guide management, suggests ...

Jun 15th, 2020 - Figure 1. Hemophagocytosis in the bone marrow. The diagnosis of HLH is based on clinical criteria. Diagnostic criteria that were developed by the Histiocyte Society for HLH (HLH-2004 criteria) are the most commonly used. They include: Fever: ≥ 7 d...

Jun 2nd, 2020 - Figure 2. Xanthelasmata around the eyelids. Biopsy of cutaneous lesions, such as xanthomas and xanthelasmas, can be helpful in cases in which the diagnosis of FH is unclear. Xanthelasmas and xanthomas of FH will contain accumulated cholesterol, wh...

Mar 3rd, 2020 - Hypertriglyceridemia (HTG) is a very common problem in clinical practice with a prevalence of approximately 10%.1 Plasma triglyceride (TG) concentration is a biomarker for TG rich lipoproteins (TRL) and their remnants, which have emerged as import...